Idera Pharmaceuticals, Inc. (IDRA) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201620162017201720182018201920192020202020212021202220220%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%-10000%-10000%Profit Margin
Profit Margin
Revenue
Earnings

IDRA Income statement / Annual

Last year (2022), Idera Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2022, Idera Pharmaceuticals, Inc.'s net income was -$23.36 M. See Idera Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $0.00 $0.00 $0.00 $1.45 M $662.00 K $902.00 K $16.20 M $249.00 K $73.00 K $47.00 K
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $1.45 M $662.00 K $902.00 K $16.20 M $249.00 K $73.00 K $47.00 K
Gross Profit Ratio 0 0 0 1 1 1 1 1 1 1
Research and Development Expenses $12.19 M $16.38 M $24.77 M $34.85 M $41.84 M $50.65 M $39.82 M $33.70 M $27.49 M $10.48 M
General & Administrative Expenses $12.21 M $9.98 M $11.92 M $12.48 M $15.42 M $16.72 M $15.13 M $15.40 M $11.33 M $7.74 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.21 M $9.98 M $11.92 M $12.48 M $15.42 M $16.72 M $15.13 M $15.40 M $11.33 M $7.74 M
Other Expenses $8.28 M $1.32 M $0.00 $181.00 K $4.36 M $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $32.68 M $27.67 M $36.69 M $47.33 M $57.26 M $67.37 M $54.96 M $49.10 M $38.83 M $18.22 M
Cost And Expenses $32.68 M $27.67 M $36.69 M $47.33 M $57.26 M $67.37 M $54.96 M $49.10 M $38.83 M $18.22 M
Interest Income $0.00 $9.00 K $165.00 K $1.15 M $1.09 M $574.00 K $415.00 K $357.00 K $0.00 $0.00
Interest Expense $204.00 K $7.00 K $3.00 K $0.00 $11.00 K $50.00 K $80.00 K $105.00 K $0.00 $0.00
Depreciation & Amortization $1.66 M $22.00 K $61.00 K $120.00 K $432.00 K $746.00 K $656.00 K $488.00 K $206.00 K $137.00 K
EBITDA -$27.82 M $98.12 M -$112.60 M -$56.40 M -$59.44 M -$65.19 M -$37.65 M -$47.96 M -$38.44 M -$18.09 M
EBITDA Ratio 0 0 0 -38.95 -89.79 -72.27 -2.32 -192.62 -526.52 -384.87
Operating Income Ratio 0 0 0 -31.81 -92.08 -73.69 -2.39 -196.17 -530.85 -386.57
Total Other Income/Expenses Net -$1.86 M $125.76 M -$75.98 M -$10.45 M $1.08 M $483.00 K $368.00 K $291.00 K $110.00 K -$57.00 K
Income Before Tax -$29.68 M $98.09 M -$112.66 M -$84.56 M -$59.88 M -$65.98 M -$38.39 M -$48.56 M -$38.64 M -$18.23 M
Income Before Tax Ratio 0 0 0 -58.4 -90.45 -73.15 -2.37 -195 -529.34 -387.79
Income Tax Expense -$6.32 M $7.00 K -$75.97 M -$10.45 M $1.09 M $533.00 K $448.00 K $396.00 K $110.00 K -$57.00 K
Net Income -$23.36 M $98.08 M -$112.66 M -$84.56 M -$59.88 M -$65.98 M -$38.39 M -$48.56 M -$38.64 M -$18.23 M
Net Income Ratio 0 0 0 -58.4 -90.45 -73.15 -2.37 -195 -529.34 -387.79
EPS -7.18 49.3 -56.63 -33.66 -38.27 -57.01 -40.92 -57.38 -63.45 -56.46
EPS Diluted -7.18 49.3 -56.63 -33.66 -38.27 -57.01 -40.92 -57.38 -63.45 -56.46
Weighted Average Shares Out $3.26 M $1.99 M $1.99 M $1.68 M $1.57 M $1.16 M $938.21 K $846.27 K $609.02 K $322.84 K
Weighted Average Shares Out Diluted $3.26 M $1.99 M $1.99 M $1.68 M $1.57 M $1.16 M $938.21 K $846.27 K $609.02 K $322.84 K
Link